BACKGROUND: Depressed mood has been associated with decreased white matter and reduced hippocampal volumes. However, the relationship between brain structure and mood may be unique among adolescents who use marijuana heavily. The goal of this study was to examine the relationship between white matter and hippocampal volumes and depressive symptoms among adolescent marijuana users and controls. METHODS: Data were collected from marijuana users (n = 16) and demographically similar controls (n = 16) aged 16-18. Extensive exclusionary criteria included psychiatric and neurologic disorders, including major depression. Substance use, mood, and anatomical measures were collected after 28 days of monitored abstinence. RESULTS: Marijuana (MJ) users demonstrated more depressive symptoms than controls (p < .05). MJ use (beta = .42, p < .005) and smaller white matter volume (beta = -.34, p < .03) each predicted higher levels of depressive symptoms on the Hamilton Depression Rating Scale. MJ use interacted with white matter volume (beta = -.55, p < .03) in predicting depression scores on the Beck Depression Inventory: among MJ users, but not controls, white matter volume was negatively associated with depressive symptoms. CONCLUSIONS: Marijuana use and white matter volume were additive and interactive in predicting depressive symptoms among adolescents. Subtle neurodevelopmental white matter abnormalities may disrupt the connections between areas involved in mood regulation.
BACKGROUND: Depressed mood has been associated with decreased white matter and reduced hippocampal volumes. However, the relationship between brain structure and mood may be unique among adolescents who use marijuana heavily. The goal of this study was to examine the relationship between white matter and hippocampal volumes and depressive symptoms among adolescent marijuana users and controls. METHODS: Data were collected from marijuana users (n = 16) and demographically similar controls (n = 16) aged 16-18. Extensive exclusionary criteria included psychiatric and neurologic disorders, including major depression. Substance use, mood, and anatomical measures were collected after 28 days of monitored abstinence. RESULTS:Marijuana (MJ) users demonstrated more depressive symptoms than controls (p < .05). MJ use (beta = .42, p < .005) and smaller white matter volume (beta = -.34, p < .03) each predicted higher levels of depressive symptoms on the Hamilton Depression Rating Scale. MJ use interacted with white matter volume (beta = -.55, p < .03) in predicting depression scores on the Beck Depression Inventory: among MJ users, but not controls, white matter volume was negatively associated with depressive symptoms. CONCLUSIONS:Marijuana use and white matter volume were additive and interactive in predicting depressive symptoms among adolescents. Subtle neurodevelopmental white matter abnormalities may disrupt the connections between areas involved in mood regulation.
Authors: Glenda M MacQueen; Stephanie Campbell; Bruce S McEwen; Kathryn Macdonald; Shigeko Amano; Russell T Joffe; Claude Nahmias; L Trevor Young Journal: Proc Natl Acad Sci U S A Date: 2003-01-24 Impact factor: 11.205
Authors: Adrian J Lloyd; I Nicol Ferrier; Robert Barber; Anil Gholkar; Allan H Young; John T O'Brien Journal: Br J Psychiatry Date: 2004-06 Impact factor: 9.319
Authors: Ramin S Hastings; Ramin V Parsey; Maria A Oquendo; Victoria Arango; J John Mann Journal: Neuropsychopharmacology Date: 2004-05 Impact factor: 7.853
Authors: Martina Ballmaier; Arthur W Toga; Rebecca E Blanton; Elizabeth R Sowell; Helen Lavretsky; Jeffrey Peterson; Daniel Pham; Anand Kumar Journal: Am J Psychiatry Date: 2004-01 Impact factor: 18.112
Authors: Susanna L Fryer; Lawrence R Frank; Andrea D Spadoni; Rebecca J Theilmann; Bonnie J Nagel; Alecia D Schweinsburg; Susan F Tapert Journal: Brain Cogn Date: 2008-03-17 Impact factor: 2.310
Authors: Krista Lisdahl Medina; Karen L Hanson; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert Journal: J Int Neuropsychol Soc Date: 2007-09 Impact factor: 2.892
Authors: Tam T Nguyen-Louie; Georg E Matt; Joanna Jacobus; Irene Li; Claudia Cota; Norma Castro; Susan F Tapert Journal: Alcohol Clin Exp Res Date: 2017-10-30 Impact factor: 3.455
Authors: Hila Abush; Subroto Ghose; Erin A Van Enkevort; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Matcheri S Keshavan; Carol A Tamminga; Elena I Ivleva Journal: Psychiatry Res Neuroimaging Date: 2018-03-28 Impact factor: 2.376
Authors: Barbara J Weiland; Rachel E Thayer; Brendan E Depue; Amithrupa Sabbineni; Angela D Bryan; Kent E Hutchison Journal: J Neurosci Date: 2015-01-28 Impact factor: 6.167
Authors: Karen L Hanson; Jennifer L Winward; Alecia D Schweinsburg; Krista Lisdahl Medina; Sandra A Brown; Susan F Tapert Journal: Addict Behav Date: 2010-06-13 Impact factor: 3.913
Authors: Matthew J Smith; Derin J Cobia; James L Reilly; Jodi M Gilman; Andrea G Roberts; Kathryn I Alpert; Lei Wang; Hans C Breiter; John G Csernansky Journal: Hippocampus Date: 2015-03-11 Impact factor: 3.899